These mutations, which primarily occur at C228T and C250T, create novel Ets/TCF binding sites, leading to aberrant TERT expression and sustained telomerase activity.120 The high prevalence of these genes in GBMs and other diffuse GBMs highlights their role in tumor maintenance and resistance to apoptosis. This evidence concerns the gene TERT and neoplasm.